Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
DEL PRIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership8,423,999 shares
Ownership 7.30%
BlackRock, Inc. ownership in 9EH / Evolent Health, Inc.

2024-01-26 - BlackRock, Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,423,999 shares of Evolent Health, Inc. (DE:9EH). This represents 7.3 percent ownership of the company. In their previous filing dated 2023-01-31 , BlackRock, Inc. had reported owning 7,701,919 shares, indicating an increase of 9.38 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-01-26 2024-01-26 13G/A 7,701,919 8,423,999 9.38 7.30 -3.95
2023-01-31 2023-01-31 13G/A 5,889,963 7,701,919 30.76 7.60 15.15
2022-02-03 2022-02-03 13G/A 5,602,233 5,889,963 5.14 6.60 1.54
2021-01-29 2021-01-29 13G/A 6,368,339 5,602,233 -12.03 6.50 -14.47
2020-02-05 2020-02-05 13G/A 4,668,237 6,368,339 36.42 7.60 26.67
2019-02-08 2019-02-08 13G 4,668,237 4,668,237 0.00 6.00 0.00
2019-02-07 2019-02-07 13G 3,721,026 4,668,237 25.46 6.00 20.48
2018-02-09 2018-02-09 13G/A 3,762,203 3,721,026 -1.09 4.98 -0.40
2018-02-01 2018-02-01 13G 3,762,203 5.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 10,888,872 557,321 5.39 24,827 -39.93 0.0000
2026-02-12 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 10,331,551 1,017,390 10.92 41,326 -47.55 0.0007
2025-11-12 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 9,314,161 -62,459 -0.67 78,798 -25.37 0.0014
2025-08-12 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 9,376,620 147,566 1.60 105,581 20.80 0.0020
2025-05-02 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 9,229,054 -94,180 -1.01 87,399 -16.67 0.0018
2025-02-07 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 9,323,234 524,923 5.97 104,886 -57.85 0.0021
2024-11-13 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 8,798,311 111,301 1.28 248,816 49.80 0.0052
2024-08-13 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 8,687,010 391,628 4.72 166,096 -38.94 0.0038
2024-05-10 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 8,295,382 -129,420 -1.54 272,006 -2.25 0.0063
2024-02-13 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 8,424,802 586,059 7.48 278,271 30.37 0.0071
2023-11-13 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 7,838,743 242,827 3.20 213,449 -7.26 0.0061
2023-08-11 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 7,595,916 667,658 9.64 230,156 2.37 0.0063
2023-05-12 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 6,928,258 -773,661 -10.05 224,822 3.95 0.0066
2023-02-13 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 7,701,919 239,355 3.21 216,270 -19.34 0.0068
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 7,462,564 1,115,264 17.57 268,129 37.56 0.0091
2022-08-12 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 6,347,300 166,308 2.69 194,923 -2.36 0.0063
2022-05-12 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 6,180,992 291,029 4.94 199,644 22.50 0.0054
2022-02-10 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 5,889,963 290,576 5.19 162,974 -6.11 0.0041
2021-11-09 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 5,599,387 -182,850 -3.16 173,580 42.14 0.0049
2021-08-11 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 5,782,237 -129,945 -2.20 122,120 2.25 0.0034
2021-05-07 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 5,912,182 309,949 5.53 119,427 32.99 0.0035
2021-02-05 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 5,602,233 320,848 6.08 89,804 37.02 0.0029
2020-11-06 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 5,281,385 -543,239 -9.33 65,542 58.04 0.0024
2020-08-14 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 5,824,624 137,247 2.41 41,471 34.29 0.0017
2020-05-01 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 5,687,377 -680,962 -10.69 30,882 -46.42 0.0015
2020-02-13 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 6,368,339 -116,086 -1.79 57,633 23.61 0.0022
2019-11-08 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 6,484,425 1,410,997 27.81 46,623 15.59 0.0020
2019-08-22 2019-06-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 5,073,428 282,951 5.91 40,334 -33.07 0.0017
2019-08-13 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 5,073,428 282,951 40,334
2019-05-09 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 4,790,477 122,240 2.62 60,264 -35.29 0.0027
2019-02-08 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 4,668,237 96,466 2.11 93,130 -28.27 0.0047
2018-11-09 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 4,571,771 209,540 4.80 129,838 41.40 0.0056
2018-08-09 2018-06-30 13F EVOLENT HEALTH CL A 30050B101 4,362,231 605,714 16.12 91,823 71.53 0.0042
2018-05-09 2018-03-31 13F EVOLENT HEALTH CL A 30050B101 3,756,517 -5,686 -0.15 53,532 15.68 0.0026
2018-02-09 2017-12-31 13F EVOLENT HEALTH CL A 30050B101 3,762,203 352,524 10.34 46,274 -23.76 0.0022
2017-11-14 2017-09-30 13F EVOLENT HEALTH CL A 30050B101 3,409,679 995,057 41.21 60,693 -0.85 0.0031
2017-08-10 2017-06-30 13F EVOLENT HEALTH CL A 30050B101 2,414,622 1,353,763 127.61 61,211 158.73 0.0032
2017-05-12 2017-03-31 13F EVOLENT HEALTH CL A 30050B101 1,060,859 1,056,153 22,442.69 23,658 33,697.14 0.0013
2017-02-10 2016-12-31 13F EVOLENT HEALTH CL A 30050B101 4,706 200 4.44 70 -36.94 0.0001
2016-11-08 2016-09-30 13F EVOLENT HEALTH CL A 30050B101 4,506 867 23.83 111 58.57 0.0002
2016-08-10 2016-06-30 13F EVOLENT HEALTH CL A 30050B101 3,639 2,257 163.31 70 366.67 0.0001
2016-05-10 2016-03-31 13F EVOLENT HEALTH CL A 30050B101 1,382 1,382 0.00 15 0.0000
2015-11-13 2015-09-30 13F EVOLENT HEALTH CL A 30050B101 0 -6,300 -100.00 0 -100.00
2015-08-07 2015-06-30 13F EVOLENT HEALTH CL A 30050B101 6,300 6,300 123 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.